Morgan Stanley View Ray, Inc. Transaction History

Morgan Stanley

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 14, 2023	BUY	$0.35 - $3.28 $130,094 - $1.22 Million	371,700 Added 61.69%	974,260 $340,000
Q1 2023 May 15, 2023	SELL	$3.28 - $4.81 $519,643 - $762,038	-158,428 Reduced 20.82%	602,560 $2.08 Million
Q4 2022 Feb 14, 2023	BUY	$3.65 - $4.82 $1.01 Million - $1.34 Million	277,014 Added 57.24%	760,988 $3.41 Million
Q3 2022 Nov 14, 2022	SELL	$2.66 - $3.97 $168,385 - $251,312	-63,303 Reduced 11.57%	483,974 $1.76 Million
Q2 2022 Oct 27, 2022	BUY	$2.42 - $4.05 $368,791 - $617,191	152,393 Added 38.59%	547,277 $1.45 Million
Q2 2022 Aug 15, 2022	BUY	$2.42 - $4.05 $368,791 - $617,191	152,393 Added 38.59%	547,277 $1.45 Million
Q1 2022 Oct 27, 2022	SELL	$3.45 - $5.83 $525,755 - $888,451	-152,393 Reduced 27.85%	394,884 $1.55 Million
Q1 2022 May 13, 2022	SELL	$3.45 - $5.83 $149,595 - $252,794	-43,361 Reduced 9.89%	394,884 $1.55 Million
Q4 2021 Feb 14, 2022	SELL	$4.89 - $7.59 $414,544 - $643,434	-84,774 Reduced 16.21%	438,245 $2.41 Million
Q3 2021 Nov 15, 2021	BUY	$5.18 - $7.41 $2.71 Million - $3.88 Million	523,019 New	523,019 $3.77 Million

645K

50K

30K

Ticker VRAY
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 181,010,000
Market Cap $1.81M
Description
ViewRay, Inc. designs, manufactures, and markets magnetic resonance imaging (MRI) guided radiation therapy systems to image and treat cancer patients in the United States, France, Taiwan, the United Kingdom, and internationally. The company provides MRIdian, which is an MRI guided radiation therapy system that addresses beam distortion, skin tox...

Get notified when there are updates to the investment portfolio of Morgan Stanley, based on Form 13F filings with the SEC.

Stay updated on Morgan Stanley with notifications on news.